Atlas Trials

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Clinical trial NCT02592941 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT02592941
Sponsor
PTC Therapeutics
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Duchenne Muscular Dystrophy

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.